B. Frank Gupton, Ph.D.
B. Frank Gupton, Ph.D., is the Floyd D. Gottwald Professor and Chair of the Department of Chemical and Life Science Engineering at the Virginia Commonwealth University School of Engineering. His thirty year industrial career has centered on the development and commercialization of chemical processes for pharmaceutical and agricultural applications. As Executive Director of Chemical Process Development at Boehringer Ingelheim Pharmaceuticals, he led the development and commercialization of the chemical process for the production of Nevirapine, a widely-prescribed antiviral medication for the treatment of AIDS. Gupton holds a B.S. in chemistry from the University of Richmond, an M. S. in biochemistry from the Georgia Institute of Technology, and a Ph.D. in chemistry from VCU.
Rodger Stringham, Ph.D.
Dr. Stringham leads the analytical chemistry team that supports process development at the Medicines for All Institute. He is also responsible for market intelligence, technology transfer and relationship-building with manufacturers and global health partners. Prior to joining the institute Dr. Stringham spent 11 years as the head of the process chemistry team at the Clinton Health Access Initiative. This was preceded by 18 years working as an analytical chemist in technology companies and in the pharmaceutical industry. He holds both B.S. and M.S. degrees from Virginia Tech as well as a Ph.D. from Purdue University.
Bruce V. Thomas J.D.
Bruce Thomas is a recognized expert in the areas of medication adherence and access, with experience leading efforts to address these issues at scale to improve patients’ lives. As a consultant and grantee to the Bill & Melinda Gates Foundation since 2014, he leads the development, testing and scale-up of new approaches to improve differentiated care for TB and HIV patients in China, India, and Sub-Saharan Africa. In his work with VCU’s Medicines For All Institute, he works to ensure that the global health community capitalizes fully on the Institute’s innovative approaches to improve access to lifesaving treatments. He previously served as president of MeadWestvaco Healthcare, establishing a proprietary manufacturing system and supply chain in India to bring generic pharmaceutical products to North America in ready-to-dispense, adherence-enhancing packaging for Walmart’s breakthrough $4 generic program.
Anita leads M4All’s outreach to manufacturing partners across the HIV, TB and Malaria pharmaceutical landscape. In addition, she engages critical procurement partners to support the institute’s effort to improve access to safe, effective and affordable medicines. She has extensive experience in the global health sector through her previous working experience with the Clinton Health Access Initiative, IBM, and PATH. Anita holds a B.S. in Business Administration from the University of California, Berkeley and a Master’s in Public Administration from Harvard University.